This work demonstrates for the first time that binding of various compounds within subdomain IB of human serum albumin (HSA) provokes characteristic changes in the near-UV circular dichroism (CD) spectrum of the protein. It can be inferred from the spectroscopic features of difference ellipticity signals and from CD displacement experiments that tyrosine residues located in subdomain IB are the source of the observed CD spectral alterations. It is proposed that inclusion of some ligand molecules (bile acids, dehydroepiandrosterone sulfate, steroidal terpenes, fatty acids, ibuprofen, and gemfibrozil) into the pocket of subdomain IB disrupts the Tyr138-Tyr161 interhelical π-π stacking interaction which is reflected in the CD spectrum. This phenomenon can be utilized for the CD detection of subdomain IB specific binding of endo-as well as exogenous agents and to study the drug binding associated local conformational adaptation of the HSA molecule.
Introduction
Human serum albumin (HSA) is a ubiquitous constituent of blood serum where it is present in millimolar concentration (~0.6 mM). The single polypeptide chain of HSA is folded into a multidomain structure composed from three homologous domains (I-III), each of which is divided into two subdomains, termed A and B, having six and four α-helices, respectively.
HSA accounts for the binding and transportation of a large number of chemical entities including pharmaceutical substances as well as endogenous compounds. Two principal drug binding regions of HSA called as Sudlow's sites were described several decades ago and characterized extensively by huge number of solution binding studies. [1] [2] [3] [4] Subsequently, X-ray crystallographic investigations provided high-resolution insight into the architecture and ligand binding properties of these pockets situated in subdomain IIA (site IIA) and IIIA (site IIIA), respectively. [5] [6] [7] [8] [9] [10] [11] In addition, the existence of a third, separate ligand binding area, different from the conventional Sudlow's sites has also been suggested by several authors. [12] [13] [14] [15] [16] [17] This binding locus called as the digitoxin site is responsible for the interactions of bile acids, digitoxin, digoxin and related cardenolides. 16, 18, 19 Neither the lone tryptophan (Trp214 at site IIA), nor the Tyr411 residue (site IIIA) is associated with the digitoxin site but some other Tyr side chains are strongly involved. 16 Moreover, this area is not identical with the high-affinity fatty acid (FA) binding sites. 18 In line with these features, a recent study using recombinant domains of HSA demonstrated the primary binding of digitoxin to domain I 20 which contains five Tyr residues and hosts a low-affinity FA site.
5,21, 22 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   4 control was provided by a Peltier thermostat equipped with magnetic stirring. Each spectrum represents the average of three scans obtained by collecting data at scan speed of 100 nm/min. CD curves of ligand-HSA mixtures were corrected by subtracting spectral contributions of ligand-free HSA (Fig. 2) .
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Near-UV CD spectroscopic profile of HSA
Since there are no peptide bond transitions in the near-UV region of proteins (240-320 nm) the CD spectrum gives information about the chiral environment around the aromatic side chains as well as on the asymmetry of disulfide bridges. HSA contains 18 tyrosines, 31 phenylalanines, a lone tryptophan residue (Trp214), and 17 pairs of disulfide bonds. Accordingly, the near-UV CD curve of HSA is the sum of the intrinsic chiroptical contribution of these residues (Fig. 2) throughout the near-UV spectrum). Therefore, the negative peaks resolved around 262 and 268 nm most likely are of Phe origin, while the shoulders near 276 and 283 nm can be assigned to the tyrosyl residues. The low energy, broad negative tail of the CD curve extending to 315 nm represents the disulfide contribution.
Effect of bile acids and steroidal saponins on the near-UV CD spectrum of HSA
Due to the presence of several chiral centers bile acids exhibit intrinsic CD signals which are displayed below 220 nm where the n-π * and π-π * transitions of the carboxylate moiety occur.
Thus, any ellipticity changes observed in the near-UV CD spectra of bile acid-HSA complexes can exclusively be ascribed to the structural modification of the protein matrix provoked by accomodation of the ligand molecules. In relation to the ligand-free state, 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 addition of chenodeoxycholic (CHN), ursodeoxycholic (URS) and glycochenodeoxycholic acid (GCHN) substantially changes the CD spectrum of HSA. Upon increasing the bile acid concentration of sample solutions, increase of the ellipticity values of HSA could be observed.
The difference ellipticity curves obtained by subtracting the CD contribution of the ligandfree protein from that of the bile acid-HSA complexes display partially resolved negative extrema between 275 and 290 nm together with less intense peaks below 270 nm (Fig. 3) . It is to be noted that these spectral changes started to develop upon addition of the first aliquots of bile acid stock solutions.
The less intense difference CD peaks induced by glycocholic and taurocholic acid were displayed only when these ligands were added in excess (Fig. 4) .
HSA binding of carbenoxolone (CRB) and 18β-glycyrrhetinic acid (18β-GLC) gave rise to similar results: the difference CD curves exhibited a negative peak and a shoulder around 286 and 282 nm (Fig. 5) . Importantly, in protein-free solution no negative signals are shown in the intrinsic CD spectra of these molecules. Distinctly from CRB, the negative ellipticity signals induced by 18β-GLC appeared at higher, around a 1:1 steroid:HSA molar ratio.
Additional steroid ligands of HSA including digoxin and fusidic acid failed to induce any CD spectral changes (data not shown).
HSA binding location of bile acids: evaluation by CD displacement experiments
CD markers of the main drug binding regions of HSA can successfully be employed to identify binding sites of ligand molecules. In protein bound state, these markers display characteristic induced CD (ICD) bands, which decrease upon addition of competing agents indicating a common binding area. The subdomain IB binding of CHN, URS, CRB, and GLC has previously been verified showing competition with the site IB label biliverdin and compound 3. 23 In the literature, however, there are some data on the subdomain IIA and IIIA (Fig. 6 ). Upon addition of bile acids (CHN, URS, glycoCHN, glycocholic acid), the long-wavelength, negative ICD band of azapropazone and diazepam
were not affected, but new, negative ellipticity signals induced below 300 nm, superposed on the ICD curves of the HSA bound marker drugs. After correction with the induced ellipticity contribution of the CD labels, the resulting difference bands display very similar shape and position to that found with binary steroid-HSA complexes (Fig. 6 ).
CD spectroscopic changes induced by HSA association of fatty acids, therapeutic drugs, and dehydroepiandrosterone sulfate
The crystallographically verified seven common binding sites of medium and long-chain nonesterified FAs are asymmetrically distributed across the three domains of HSA (FA sites 1-7). 5, 29 The three highest-affinity sites (2, 4, and 5) are situated at the interface between subdomain IA and IIA, within IIIA, and IIIB, respectively. 21 The additional, lower-affinity FA sites designated as 1, 3, 6, and 7 are hosted within subdomain IB, IIIA, and IIA/IIB.
According to NMR studies, only the highest-affinity sites are occupied at 2:1 FA:HSA molar ratio but above the ratio of 3:1, population of the lower-affinity sites also begins. 22 During titration of HSA samples with concentrated stock solution of myristic, palmitic, and oleic acid, the CD spectrum remained constant up to FA:HSA molar ratio of 3. Above of this value, however, negative difference CD peaks were evolved in parallel with the increase of the FA concentration in the sample solutions ( Fig. 7) . No further ellipticity changes were measured after reaching 6 mole equivalents of FA.
The ligand binding pocket of subdomain IIIA preferentially accomodates stick like molecules with a peripherial, negatively charged group 30 . The antiinflammatory and antilipemic drug ibuprofen and gemfibrozil are considered as stereotypical ligands of this site. 4, 30 Up to 1 mole equivalent of these drugs, no CD spectral changes were detected. Further raising of the drug:HSA ratio resulted in the appearance of multiple, negative difference ellipticity bands below 300 nm ( . Two sets of HSA binding sites, a primary and a secondary one were found for DHEAS, but their location is still unknown. 31 Due to the presence of the chirally perturbed saturated ketone moiety, DHEAS exhibits a positive intrinsic CD band of n-π * origin, which completely overlaps with the aromatic CD region of HSA (Fig. 9 ). Upon addition of DHEAS into albumin solution, this CD peak shows a striking transformation: in relation to the symmetrical, bell shaped curve measured in aqueous buffer, the short-wavelength side of the peak looses intensity and displayes a well-resolved vibronic progression (Fig. 9 ). These prominent spectral alterations can be detected from the beginning of the titration, even at low DHEAS:HSA molar ratios. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 protein-free state from the spectrum measured with HSA results in a negative difference peak showing very similar shape and position to that obtained with bile acids (cf. Fig. 3 ).
Effect of steroids and gemfibrozil on the near-UV CD profile of hemin-HSA complexes
In analogy with the CD titrations when addition of bile acids generated characteristic ellipticity signals superimposed on the ICD curve of HSA bound site labels (Fig. 6 ), the effect of bile acids, CRB, GLC, DHEAS and gemfibrozil on the ICD spectrum of hemin-HSA complexes was also studied. The large macrocycle of hemin completely occupies the site IB cavity where it binds with very high affinity (K a ~ 10 8 M -1 ). 6 Inclusion of hemin induces multiple CD peaks allied to its absorption bands. 28, 32 The broad, negative ICD band of hemin displayed between 250-300 nm showed neither shape nor intensity changes upon addition of these ligands (data not shown). The intrinsic CD peak of DHEAS measured in the presence of hemin-HSA complexes is very similar to that found in Ringer buffer but was red shifted by 5 nm (Fig. 9 ).
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Tyr138 and Tyr 161 are involved in the ligand binding of subdomain IB, Tyr150 is located in the binding cavity of subdomain IIA, while Tyr411 interacts with guest molecules accomodated within subdomain IIIA. 5, 9, 30, 35 Taking into account the CD spectroscopic changes only, it could not be clarified which Tyr residues are responsible for the observed CD spectroscopic changes. In this context, however, CD displacement experiments provide valuable data. In spite of the presence of a site IIA specific marker azapropazone, steroid compounds were able to induce near-UV ellipticity changes (Fig. 6) . Similarly, the use of the It is also shown that pre-occupation of the cavity of subdomain IB with a hemin molecule cancels the ability of ligand molecules to induce difference CD signals which highlights the role of tyrosyl residues of this binding region. Crystallographic data have showed that accomodation of hemin induces large rotation and un-stacking of the Tyr138 and Tyr161 residues. 6 In ligand-free state, the subdomain IB cavity is L-shaped due to the interhelical π-π stacking of the phenolic rings, of which ligand binding induced concerted motion transforms the pocket into D-shape allowing enough room to completely engulf the large porphyrin nucleus. Similarly, inclusion of medium and long-chain FAs into the pocket also un-stacks the Tyr residues opening up a hydrophobic tunnel for their alkyl chain 5, 29 (Fig. 10) . Due to the strong masking effect of the induced ellipticity band of hemin below 300 nm, the tyrosine related difference ellipticity signals could not be resolved in the CD spectrum. In contrast, these bands can be well observed when the conformational adjustment is induced by optically transparent FA molecules (Fig. 7) . The fact that the difference CD bands could only be 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13 FA site 1, accomodation of FA molecules at the other low-affinity sites (3, 6 , and 7) is associated with more modest conformational changes of the binding residues. 29 The CD spectroscopic results refer to that un-stacking of the Tyr residues may also occur upon the site IB binding of bile acids, DHEAS, and steroidal saponines. It seems that proper accomodation of these compounds demands rotation of the Tyr138 and Tyr161 side chains which disrupts the stacking interaction between them. Noticeably, based on unpublished crystallographic data, subdomain IB binding of certain steroid-based therapeutics has been claimed to induce similar conformational re-arrangement of that Tyr residues. 13 Curiously, HSA binding of ibuprofen above 1:1 molar ratio also induced a characteristic difference CD pattern. According to crystallographic studies, besides the primary binding site in subdomain IIIA, only a single secondary ibuprofen locus was found in the shallow trench at the interface between subdomains IIA and IIB that overlaps the low-affinity FA site 6.
30
Solution binding studies employing 2D NMR technique corroborated the association of ibuprofen to these sites but also indicated a third, previously unidentified binding area which corresponds to another low-affinity FA site. 22 In addition, as it has been concluded from displacement studies, the specific HSA binding site of glycyrrhizin (the glycosidic form of 18β-GLC) is largely in common with a low-affinity ibuprofen binding area. 37 Taken together, it can be presumed that this site is situated within subdomain IB where the Tyr138 and Tyr161 residues un-stack upon hosting of the ibuprofen ligand explaining the observed CD spectroscopic changes. In concordance with this concept, ibuprofen binding in subdomain IB has also been claimed but neither the experimental method nor the crystal structure of the complex were reported 13 . The same is true for gemfibrozil, the association of which to site IB (and IIIA) has also been described based on unpublished crystallographic data. 13 It can be assumed that the site IB binding mode of ibuprofen and gemfibrozil is similar to that of FAs: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 by un-stacking of the tyrosyl residues, while the carboxylic head forms H-bonds to an adjacent basic side chain, e.g. Arg117 (Fig. 10 ). Importantly, as the cases of FAs, ibuprofen, gemfibrozil, glyco-and taurocholic acid illustrate, CD spectroscopic changes evolved only in ligand excess may refer to the secondary site IB binding of these agents. In contrast, development of the difference ellipticity peaks below 1:1 ligand:HSA ratio suggests the primary site IB association of guest compounds (e.g., CHN, URS, CRB, DHEAS, see Fig. 3 and 4) .
It must be emphasized
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Conclusions
The present study demonstrates the characteristic modification of the near-UV CD spectrum of HSA upon binding of important endogenous as well as therapeutic drug ligands. Taking into consideration these results and previously published data, the observed CD spectroscopic changes are assigned to the Tyr138 and Tyr161 residues of subdomain IB where bile acids, DHEAS, steroidal saponines, FAs, and some pharmaceutical substances are bound.
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